Neurodegenerative Diseases
"Neurodegenerative Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Descriptor ID |
D019636
|
| MeSH Number(s) |
C10.574
|
| Concept/Terms |
Neurodegenerative Diseases- Neurodegenerative Diseases
- Neurodegenerative Disease
- Degenerative Diseases, Neurologic
- Neurologic Degenerative Disease
- Degenerative Neurologic Diseases
- Degenerative Neurologic Disease
- Neurologic Disease, Degenerative
- Neurologic Diseases, Degenerative
- Nervous System Degenerative Diseases
- Neurodegenerative Disorders
- Neurodegenerative Disorder
- Neurologic Degenerative Conditions
- Degenerative Condition, Neurologic
- Degenerative Conditions, Neurologic
- Neurologic Degenerative Condition
- Neurologic Degenerative Diseases
- Degenerative Diseases, Nervous System
- Degenerative Neurologic Disorders
- Degenerative Neurologic Disorder
- Neurologic Disorder, Degenerative
- Neurologic Disorders, Degenerative
|
Below are MeSH descriptors whose meaning is more general than "Neurodegenerative Diseases".
Below are MeSH descriptors whose meaning is more specific than "Neurodegenerative Diseases".
This graph shows the total number of publications written about "Neurodegenerative Diseases" by people in this website by year, and whether "Neurodegenerative Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 1 | 2 |
| 1999 | 3 | 0 | 3 |
| 2000 | 1 | 0 | 1 |
| 2001 | 3 | 0 | 3 |
| 2002 | 5 | 2 | 7 |
| 2003 | 3 | 1 | 4 |
| 2004 | 2 | 1 | 3 |
| 2005 | 1 | 3 | 4 |
| 2006 | 4 | 1 | 5 |
| 2007 | 3 | 3 | 6 |
| 2008 | 1 | 2 | 3 |
| 2009 | 5 | 0 | 5 |
| 2010 | 3 | 2 | 5 |
| 2011 | 3 | 4 | 7 |
| 2012 | 3 | 1 | 4 |
| 2013 | 1 | 2 | 3 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 3 | 0 | 3 |
| 2017 | 2 | 1 | 3 |
| 2018 | 2 | 2 | 4 |
| 2019 | 2 | 3 | 5 |
| 2020 | 5 | 1 | 6 |
| 2021 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neurodegenerative Diseases" by people in Profiles.
-
Groover SE, Adegbuyiro A, Fan CK, Hodges BL, Beasley M, Taylor K, Stonebraker AR, Siriwardhana C, Legleiter J. Macromolecular crowding in solution alters huntingtin interaction and aggregation at interfaces. Colloids Surf B Biointerfaces. 2021 Oct; 206:111969.
-
Bhatia-Dey N, Heinbockel T. The Olfactory System as Marker of Neurodegeneration in Aging, Neurological and Neuropsychiatric Disorders. Int J Environ Res Public Health. 2021 06 29; 18(13).
-
Toropova AP, Toropov AA, Leszczynska D, Leszczynski J. How the CORAL software can be used to select compounds for efficient treatment of neurodegenerative diseases? Toxicol Appl Pharmacol. 2020 12 01; 408:115276.
-
Masoudi Asil S, Ahlawat J, Guillama Barroso G, Narayan M. Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases. Biomater Sci. 2020 Aug 07; 8(15):4109-4128.
-
Bhatia-Dey N, Heinbockel T. Endocannabinoid-Mediated Neuromodulation in the Olfactory Bulb: Functional and Therapeutic Significance. Int J Mol Sci. 2020 Apr 19; 21(8).
-
Yeung AWK, Tzvetkov NT, Georgieva MG, Ognyanov IV, Kordos K, Józwik A, Kühl T, Perry G, Petralia MC, Mazzon E, Atanasov AG. Reactive Oxygen Species and Their Impact in Neurodegenerative Diseases: Literature Landscape Analysis. Antioxid Redox Signal. 2021 02 10; 34(5):402-420.
-
Henriquez G, Mendez L, Narayan M. A Hybrid Model to Study Amyloid Cross-Toxicity. ACS Chem Neurosci. 2020 02 05; 11(3):228-230.
-
Reyes-Pablo AE, Campa-Córdoba BB, Luna-Viramontes NI, Ontiveros-Torres MÁ, Villanueva-Fierro I, Bravo-Muñoz M, Sáenz-Ibarra B, Barbosa O, Guadarrama-Ortíz P, Garcés-Ramírez L, de la Cruz F, Harrington CR, Martínez-Robles S, González-Ballesteros E, Perry G, Pacheco-Herrero M, Luna-Muñoz J. National Dementia BioBank: A Strategy for the Diagnosis and Study of Neurodegenerative Diseases in México. J Alzheimers Dis. 2020; 76(3):853-862.
-
Gao J, Wang L, Gao C, Arakawa H, Perry G, Wang X. TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease. Biochim Biophys Acta Mol Basis Dis. 2020 01 01; 1866(1):165580.
-
Wang J, Enriquez AS, Li J, Rodriguez A, Holguin B, Von Salzen D, Bhatt JM, Bernal RA. MitCHAP-60 and Hereditary Spastic Paraplegia SPG-13 Arise from an Inactive hsp60 Chaperonin that Fails to Fold the ATP Synthase ß-Subunit. Sci Rep. 2019 08 23; 9(1):12300.